New Antiviral on the Horizon for Mild to Moderate COVID-19
JAMA
.
2024 Mar 12;331(10):821.
doi: 10.1001/jama.2024.0729.
Author
Emily Harris
PMID:
38381468
DOI:
10.1001/jama.2024.0729
No abstract available
MeSH terms
Antiviral Agents* / therapeutic use
COVID-19 Drug Treatment* / trends
COVID-19* / therapy
Humans
SARS-CoV-2
Substances
Antiviral Agents